Clinical Trial Update: Hydrocortisone Treatment for Symmetric Lipomatosis Associated With Neuropathy (SLN): an N-of-1 Study Hydrocortisone Treatment for Symmetric Lipomatosis Associated With Neuropathy (SLN): an N-of-1 Study [Phase 3]

View source ↗

Summary

A Phase 3 trial investigating hydrocortisone for symmetric lipomatosis with neuropathy (SLN) is listed, with status currently UNKNOWN.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple
• Symmetric Lipomatoses

Drugs mentioned

• HYDROCORTISONE (HYDROCORTISONE)

Snippet

Sponsor: Erasmus Medical Center | Conditions: Symmetric Lipomatoses, Multiple | Phase 3 | Status: UNKNOWN